Interferon‐α Is Effective for Treatment of Minimal Residual Disease in Patients with t(8;21) Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation: Results of a Prospective Registry Study
2018 ◽
Vol 23
(11)
◽
pp. 1349-1357
◽
2016 ◽
Vol 58
(5)
◽
pp. 1135-1143
◽
2011 ◽
Vol 18
(6)
◽
pp. 381-387
◽
2021 ◽
Vol 27
(3)
◽
pp. S161-S162
2021 ◽
Vol 27
(3)
◽
pp. S130-S131
2018 ◽
Vol 25
(6)
◽
pp. 425-432
◽
2020 ◽
Vol 26
(1)
◽
pp. 215
2019 ◽
Vol 25
(10)
◽
pp. 1925-1932
◽